Literature DB >> 17120186

Identification and molecular characterization of a novel splice-site mutation (G1205C) in the SQSTM1 gene causing Paget's disease of bone in an extended American family.

G Beyens1, W Wuyts, E Cleiren, F de Freitas, R Tiegs, W Van Hul.   

Abstract

Paget's disease of bone (PDB) is a common late-onset bone disorder characterized by focal areas of abnormal bone remodeling. Positional cloning efforts resulted in the identification of seven genetic loci (PDB1-7) with putative involvement in the pathogenesis of PDB. Meanwhile, the PDB-causing gene from the PDB3 region on chromosome 5q35 has been identified as the SQSTM1 gene. All mutations identified in this gene so far are located in or close to the ubiquitin-associated (UBA) domain of the protein. In 2001, we reported genotyping results of genetic markers located in the PDB3 region in an extended American family, indicating the involvement of the PDB3 locus. Here, we report the identification of a novel mutation (G1205C) in the SQSTM1 gene in this family. The G1205C mutation is located in the splice donor site of intron 7 and reverse-transcription polymerase chain reaction experiments showed that the presence of the C allele results in the production of two abnormal mRNA transcripts. Translation of the first transcript would result in a protein that lacks amino acids 351-388, including 26 amino acids of the second PEST domain in addition to two amino acids of the UBA domain. The second mutant mRNA transcript could result in a truncated protein (390X) that lacks almost the complete UBA domain. PDB mutations that disrupt the function of the PEST domain of SQSTM1 have not been reported before, so probably the pathogenic effect of both transcripts resides in the disruption of the ubiquitin-binding properties of the protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17120186     DOI: 10.1007/s00223-006-0122-3

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  6 in total

1.  The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.

Authors:  Pui Yan Jenny Chung; Greet Beyens; Steven Boonen; Socrates Papapoulos; Piet Geusens; Marcel Karperien; Filip Vanhoenacker; Leon Verbruggen; Erik Fransen; Jan Van Offel; Stefan Goemaere; Hans-Georg Zmierczak; René Westhovens; Jean-Pierre Devogelaer; Wim Van Hul
Journal:  Hum Genet       Date:  2010-09-14       Impact factor: 4.132

2.  Alternative splicing in osteoclasts and Paget's disease of bone.

Authors:  Roscoe Klinck; Gino Laberge; Martine Bisson; Stephen McManus; Laëtitia Michou; Jacques P Brown; Sophie Roux
Journal:  BMC Med Genet       Date:  2014-08-14       Impact factor: 2.103

Review 3.  Clinical and Genetic Advances in Paget's Disease of Bone: a Review.

Authors:  N Alonso; I Calero-Paniagua; J Del Pino-Montes
Journal:  Clin Rev Bone Miner Metab       Date:  2016-12-19

4.  Molecular insights into an ancient form of Paget's disease of bone.

Authors:  Barry Shaw; Carla L Burrell; Darrell Green; Ana Navarro-Martinez; Daniel Scott; Anna Daroszewska; Rob van 't Hof; Lynn Smith; Frank Hargrave; Sharad Mistry; Andrew Bottrill; Benedikt M Kessler; Roman Fischer; Archana Singh; Tamas Dalmay; William D Fraser; Kirstin Henneberger; Turi King; Silvia Gonzalez; Robert Layfield
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

5.  Targeted sequencing of DCSTAMP in familial Paget's disease of bone.

Authors:  M A Sultana; N J Pavlos; Lynley Ward; J P Walsh; S L Rea
Journal:  Bone Rep       Date:  2019-02-21

6.  Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function.

Authors:  Alice Goode; Jed E Long; Barry Shaw; Stuart H Ralston; Micaela Rios Visconti; Fernando Gianfrancesco; Teresa Esposito; Luigi Gennari; Daniela Merlotti; Domenico Rendina; Sarah L Rea; Melanie Sultana; Mark S Searle; Robert Layfield
Journal:  Biochim Biophys Acta       Date:  2014-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.